Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients

Asymmetric Dimethylarginine Is a Marker of Endothelial Dysfunction in Thrombotic Antiphospholipid Syndrome Patients

Objective: The potential contribution of asymmetric dimethylarginine (ADMA) and high-sensitivity C reactive protein (hsCRP) to endothelial dysfunction in APS patients has not been studied in detail, until now. The study involved 105 APS patients (59 diagnosed with primary APS (PAPS) and 46 APS assoc...

Full description

Bibliographic Details
Main Authors: Natasa Stanisavljevic, Ljudmila Stojanovich, Aleksandra Djokovic, Brankica Todic, Violeta Dopsaj, Jovica Saponjski, Dusan Saponjski, Olivera Markovic, Cristina Belizna, Marija Zdravkovic, Dragomir Marisavljevic
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:International Journal of Molecular Sciences
Subjects:
antiphospholipid syndrome
lupus erythematosus
systemic
inflammation
Online Access:https://www.mdpi.com/1422-0067/23/20/12309

Internet

https://www.mdpi.com/1422-0067/23/20/12309

Similar Items